11 – 20 of 113
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Intralymphatic Immunotherapy : Update and Unmet Needs
(
- Contribution to journal › Article
- 2018
-
Mark
Substance P represents a novel first-line defense mechanism in the nose
(
- Contribution to journal › Article
-
Mark
Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass : A randomized, double-blind, placebo-controlled trial
(
- Contribution to journal › Letter
- 2016
-
Mark
Novel strategies for the treatment of grass pollen-induced allergic rhinitis
(
- Contribution to journal › Scientific review
-
Mark
Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial.
(
- Contribution to journal › Article
-
Mark
Chronic rhinosinusitis patients show accumulation of genetic variants in PARS2
(
- Contribution to journal › Article
-
Mark
TOTALL: high cost of allergic rhinitis-a national Swedish population-based questionnaire study.
(
- Contribution to journal › Article
- 2014
-
Mark
LEAP-2, LL-37 and RNase7 in tonsillar tissue: downregulated expression in seasonal allergic rhinitis.
(
- Contribution to journal › Article
-
Mark
Allergen-specific immunotherapy increases plasma gelsolin levels
(
- Contribution to journal › Article
-
Mark
Haemophilus influenzae reside in tonsills and use IgD binding as an evasion strategy.
(
- Contribution to journal › Article